Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website revision was updated from v3.6.3 to v3.6.4, representing a newer platform release. There is no change to study data or page content reflected.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision indicator was updated from v3.6.2 to v3.6.3. This reflects an underlying site update but does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. No user-facing content changes are indicated.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now states recruitment has ended and introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with the Intervention/Treatment heading and a revised revision tag (Revision: v3.6.0).SummaryDifference0.6%

- Check52 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This indicates a small platform update with no change to the study information shown.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, signaling a new release of the site interface. This appears to be a maintenance update with no changes to the trial information presented on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.